Statistics

Total Visits

Views
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort11

File Visits

Downloads
1935.pdf13

Select a period of time:

Number of views in the range

Views
Mobocertinib (TAK-788) in EGFR Exon 20 Insertion+ Metastatic NSCLC: Patient-Reported Outcomes from EXCLAIM Extension Cohort11

Number of downloads in the range

Downloads
1935.pdf13

Views

Views
September 20254
October 20252
November 20253
December 20250
January 20260
February 20260
March 20262
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • September 2025
    2
  • October 2025
    0
  • November 2025
    0
  • December 2025
    0
  • January 2026
    4
  • February 2026
    3
  • March 2026
    4
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
Brazil3
Angola1
Argentina1
 

Top countries by downloads

Downloads
United States10
 

Top cities views

Views
Canavieiras1
Luanda1
Nova Lima1
Olavarría1
Parauapebas1
 

Top cities by downloads

Downloads